BioSpace News Archive

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, today announced a collaboration with Asher Biotherapeutics for systems pharmacology modeling in solid tumors.

Smiths Medical, a leading medical device manufacturer, announces the release of the ECRI evaluation report for CADD®-Solis v4 with wireless communication Patient-Controlled Analgesic (PCA) and epidural infusion pump.

Today, Olive Labs announced their partnership with Concentric by Ginkgo to provide a scalable, accessible, and simple testing modality for COVID-19 - pooled testing - to serve schools operating hybrid or in-person learning

Plano-based Allied BioScience Responds to Global Demand for First-of-its-kind Residual Product, Expansion of Product Portfolio

Gold Standard Diagnostics (GSD), a Eurofins Technologies company, today announced FDA clearance of a new B. burgdorferi IgG/IgM VlsE-OspC EIA test.

BostonGene Corporation, a biomedical software company committed to defining optimal precision medicine-based therapies for cancer patients, today announced that eight abstracts were selected for poster presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021

Tensive Controls Inc. (TCI Peptide Therapeutics), a company developing best-in-class peptide drug candidates with better safety and efficacy properties, changed its name to Endevica Bio.

The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer in the world, has announced the dosing of its first patient in a first-in-human Phase 0 clinical trial of sonodynamic therapy (SDT), a noninvasive drug-device combination developed by SonALAsense in collaboration with Insightec.

Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage biotechnology company developing transformative gene therapies for patients suffering from inherited systemic debilitating diseases, today announced that the Company will attend the following virtual investor conferences:

Reflect Scientific, Inc., a provider of diverse products and services for biotechnology, pharmaceutical, and transportation industries, announced financial results for the twelve months ended December 31, 2020.